BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7838536)

  • 21. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
    Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
    Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
    Rappaport J; Lee SJ; Khalili K; Wong-Staal F
    New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression.
    Dandekar DH; Ganesh KN; Mitra D
    Nucleic Acids Res; 2004; 32(4):1270-8. PubMed ID: 14981150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review.
    Taylor JP; Khalili K
    Adv Neuroimmunol; 1994; 4(3):291-303. PubMed ID: 7874398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
    Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
    EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
    Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA
    Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.
    Kaniowska D; Kaminski R; Amini S; Radhakrishnan S; Rappaport J; Johnson E; Khalili K; Del Valle L; Darbinyan A
    J Virol; 2006 Sep; 80(18):9288-99. PubMed ID: 16940540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
    Kim S; Yu SS; Kim VN
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
    Li X; Josef J; Marasco WA
    Biochem Biophys Res Commun; 2001 Aug; 286(3):587-94. PubMed ID: 11511100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
    Rivière Y; Blank V; Kourilsky P; Israël A
    Nature; 1991 Apr; 350(6319):625-6. PubMed ID: 2017258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of HIV transcription by human foamy virus in transgenic mice.
    Marino S; Kretschmer C; Brandner S; Cavard C; Zider A; Briand P; Isenmann S; Wagner EF; Aguzzi A
    Lab Invest; 1995 Jul; 73(1):103-10. PubMed ID: 7603032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins.
    Blázquez MV; Macho A; Ortiz C; Lucena C; López-Cabrera M; Sánchez-Madrid F; Muñoz E
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1209-18. PubMed ID: 10480634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Majello B; De Luca P; Hagen G; Suske G; Lania L
    Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
    Demarchi F; d'Adda di Fagagna F; Falaschi A; Giacca M
    J Virol; 1996 Jul; 70(7):4427-37. PubMed ID: 8676466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW; Talmage DA; Viglianti GA
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
    Berkhout B; Gatignol A; Rabson AB; Jeang KT
    Cell; 1990 Aug; 62(4):757-67. PubMed ID: 2201451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
    Doppler C; Schalasta G; Amtmann E; Sauer G
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.
    Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M
    AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.